Kazia Therapeutics Ltd ADR (KZIA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.43M |
| Enterprise Value | 6.49M |
| P/E Ratio | -1.81 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 1,535.46 |
| Price/Book Ratio | 1.26 |
| Enterprise/Revenue | -1,980.13 |
| Enterprise/EBITDA | 2.15 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1,130.05 |
| Operating Margin | -920.86 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -1.17 |
Income Statement
| Revenue | 42,000 |
| Revenue/Share | 0.01 |
| Gross Profit | 42,000 |
| EBITDA | -13.28M |
| Net Income | -20.7M |
| Diluted EPS | -18.9 |
Balance Sheet
| Total Cash | 69.39M |
| Total Cash/Share | 22.24 |
| Total Debt | 98,708 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.87 |
| Book Value Per Share | 14.88 |
Price History
| 52-Week Change | 73.87 |
| 52-Week High | 17.4 |
| 52-Week Low | 4.86 |
| Moving Average 50 Days | 13.42 |
| Moving Average 200 Days | 10.22 |
Statistics
| Average Volume | 190,956 |
| Shares Outstanding | 1.62M |
| % Held by Institutions | 56.21 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | April 17, 2025 |
AD
